Cargando…
Molecular basis of GDF15 induction and suppression by drugs in cardiomyocytes and cancer cells toward precision medicine
GDF15 has recently emerged as a key driver of the development of various disease conditions including cancer cachexia. Not only the tumor itself but also adverse effects of chemotherapy have been reported to contribute to increased GDF15. Although regulation of GDF15 transcription by BET domain has...
Autores principales: | Winter, Lisa-Maria, Reinhardt, Diana, Schatter, Ariane, Tissen, Vivien, Wiora, Heike, Gerlach, Daniel, Tontsch-Grunt, Ulrike, Colbatzky, Florian, Stierstorfer, Birgit, Yun, Seong-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372009/ https://www.ncbi.nlm.nih.gov/pubmed/37495707 http://dx.doi.org/10.1038/s41598-023-38450-w |
Ejemplares similares
-
Structural basis for potency differences between GDF8 and GDF11
por: Walker, Ryan G., et al.
Publicado: (2017) -
Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic
por: Tontsch-Grunt, Ulrike, et al.
Publicado: (2022) -
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
por: Gerlach, Daniel, et al.
Publicado: (2018) -
GDF11 Modulates Ca(2+)-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy
por: Duran, Javier, et al.
Publicado: (2018) -
FRI017 Precision-engineered Activin And GDF Ligand Trap HS235: A Novel Lean Mass-preserving Treatment for Obesity
por: Schang, Gauthier, et al.
Publicado: (2023)